 |
|
|
 |
New Study Of Coated Stent -- Long-Term Results Disappointing
A new drug-eluting stent -- a tiny spring device coated with medicine that keeps blood vessels from reblocking after angioplasty -- may have a problem holding up over time, say researchers in Tuesday's rapid access publication of Circulation: Journal of the American Heart Association. more
|
|
Point: Key Recommendations Regarding Alternative and Complementary Medicine Forwarded To President Bush And Congress
James S. Gordon, M.D., Chair of the White House Commission on Complementary and Alternative Medicine Policy forwarded to President Bush and Congress key recommendations regarding alternative and complementary medicine last week. The report included the exploration of alternative therapies and how their study might be used to improve the health of the nation's citizens. more
|
|
|
|
Counterpoint: Consumer Group Labels White House Panel Proposals Irrational
The National Council Against Health Fraud, Inc. (NCAHF) has concluded that policies prescribed in a report issued this week by the White House Commission on Complementary and Alternative Medicine Policy (WHCCAMP) would lead to widespread adoption of unproven, disproven, and irrational methods and would cost the American public billions of dollars and thousands of human lives. more
|
|
Margin Width And Tumor Size Key Factors In Predicting Whether Or Not Tumor Cells Remain After Lumpectomy
The size of the margin width excised during lumpectomy and the tumor size in the margin are the most significant factors in predicting whether or not tumor cells remain in the breast tissue after lumpectomy. Findings in a recent study published in the April 1, 2002, issue of CANCER indicate that the greater the margin of grossly normal breast tissue removed during lumpectomy and the smaller the lesion in the excised margin, the less chance there is of residual tumor being left in the breast. The study also suggests that women with a low likelihood of residual disease may be able to forgo post-operative radiation with a low risk of recurrence. more
|
|
Information For Patients: Questions And Answers About Adjuvant Therapy For Breast Cancer
Researchers have been studying breast cancer for many years to learn how best to treat this disease. They have given special attention to ways to prevent breast cancer from recurring (returning) after primary treatment. more
|
|
|
